FDA Approves First Drug for Hunter Syndrome Brain Complications in Children
Avlayah becomes the first treatment targeting neurologic symptoms of rare genetic disorder affecting 500 Americans.
989 articles in this topic
Avlayah becomes the first treatment targeting neurologic symptoms of rare genetic disorder affecting 500 Americans.
Researchers develop novel immunotherapy using modified brain cells to target Alzheimer's pathology directly in the brain.
Researchers created new CB1 receptor drugs that provide pain relief without the unwanted effects of traditional cannabis compounds.
New review reveals how protein clumps and cellular powerhouses work together to drive neurodegeneration in Parkinson's disease.
Emerging mycotoxin found in foods crosses blood-brain barrier, disrupts neurotransmitters and impairs cognitive function in animal model.
Large FDA database analysis reveals methylphenidate may reduce suicide risk while atomoxetine increases it in pediatric ADHD patients.
New analysis reveals how political contempt patterns damage international health cooperation and medical advancement worldwide.
New perspective highlights nurses' unique role in bridging research and public health messaging during health crises.
12-week mindfulness exercise program significantly improved motor tics, anxiety, and daily functioning in 121 children with Tourette syndrome.
Systematic review of 15 studies finds Kundalini yoga improves memory, reduces anxiety and PTSD, and enhances sleep quality with no serious side effects.
Large international study reveals how current antidepressant use affects brain structure in people with major depression.
NMDA receptor antagonist memantine restored social and recognition memory deficits caused by chronic methamphetamine exposure.